However, findings from a large prospective cohort within the Rotterdam Study, encompassing 6430 stroke-free individuals followed for an average of 8.2 years, indicate that the inclusion of CRP measurements into established stroke risk prediction models, such as the Framingham Stroke Risk Score, does not enhance predictive accuracy. The gene discussed is CRP; the disease is Stroke.